Houlihan Lokey Advises Qunol

Houlihan Lokey is pleased to announce that Qunol, a market-leading vitamin, mineral, and supplement company, has been acquired by Sanofi. The transaction was completed on 29 September 2023.

Founded in 2006 with the goal of delivering efficacious, science-backed health solutions, Qunol is a market leader in the VMS industry and at the forefront of the fast-growing healthy aging sector. The brand’s CoQ10 and turmeric products are differentiated solutions that combine high-quality ingredients with unique absorption technology to deliver powerful support for heart health and joint health, respectively. Qunol’s products include the No. 1 cardiologist- and doctor-recommended forms of CoQ10 and turmeric curcumin and enjoy multiple No. 1 market positions across leading club, mass, and e-commerce retailers in North America.

Sanofi is an innovative global healthcare company, driven by one purpose: to chase the miracles of science to improve people’s lives. Sanofi’s team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. Sanofi provides potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of their ambitions.

Houlihan Lokey served as the exclusive financial advisor to Qunol and assisted in structuring and negotiating the transaction on its behalf. This transaction underscores Houlihan Lokey’s deep expertise in the vitamin, mineral, and supplement sector, following the sales of Zesty Paws to H&H Group, Nuun Hydration to Nestlé Health Science, SmartyPants Vitamins to Unilever, Care/of to Bayer, and Zarbee’s to Johnson & Johnson. The transaction also strengthens the firm’s track record of working with the most innovative and disruptive brands in the health and wellness industry.